The association of tumor volume with mortality following radical prostatectomy

被引:41
作者
Knoedler, J. J. [1 ]
Karnes, R. J. [1 ]
Thompson, R. H. [1 ]
Rangel, L. J. [2 ]
Bergstralh, E. J. [2 ]
Boorjian, S. A. [1 ]
机构
[1] Mayo Clin, Dept Urol, Rochester, MN 55905 USA
[2] Mayo Clin, Dept Hlth Sci Res, Rochester, MN 55905 USA
关键词
tumor volume; radical prostatectomy; mortality; risk stratification; BIOCHEMICAL RECURRENCE; INDEPENDENT PREDICTOR; PROGNOSTIC-SIGNIFICANCE; ANTIGEN RECURRENCE; CANCER; RISK; MEN; PROGRESSION; CARCINOMA; SPECIMEN;
D O I
10.1038/pcan.2013.61
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BACKGROUND: Data regarding the prognostic significance of tumor volume (TV) in prostate cancer are conflicting. Herein, we evaluated the association of TV with prostate cancer mortality following radical prostatectomy (RP), and assessed the additive prognostic value of TV to an established predictive model. METHODS: We identified 13 687 patients who underwent RP without preoperative therapy between 1987 and 2009. TV was estimated using the prolate ellipsoid formula. Survival was estimated using the Kaplan-Meier method and compared with the log-rank test. Cox proportional hazard regression models were used to evaluate the association of TV with mortality. The ability of TV to enhance the performance of an established prognostic model (Mayo Clinic GPSM (Gleason, PSA, seminal vesicle and margin status) score) was assessed using the c-index. RESULTS: Median TV was 1.57 cm(3) (interquartile range (IQR) 0.48-4.19). Increasing TV was associated with significantly higher risks of seminal vesicle invasion (hazard ratio (HR) 1.58; P<0.0001), positive surgical margins (HR 1.28; P<0.0001) and lymph node involvement (HR 1.26; P<0.0001). Median postoperative follow-up was 9.4 years (IQR 5.0-14.5). Patient grouping into quartiles according to TV resulted in a significant stratification of outcome, as the 15-year cancer-specific survival by TV quartile was 99%, 98%, 95% and 88%, respectively (P<0.0001). Moreover, on multivariate analysis, greater TV remained associated with significantly increased risks of systemic progression (HR 1.27; P< 0.0001), death from prostate cancer (HR 1.29; P< 0.0001) and all-cause mortality (HR 1.05; P<0.0001). Meanwhile, addition of TV to the GPSM score increased the c-index for the model's prediction of prostate cancer mortality from 0.803 to 0.822. CONCLUSIONS: TV is associated with survival following RP, and enhances, although modestly, the performance of an established prediction model. As such, TV warrants continued assessment in risk stratification tools.
引用
收藏
页码:144 / 148
页数:5
相关论文
共 35 条
[1]   Defining prostate specific antigen progression after radical prostatectomy: What is the most appropriate cut point? [J].
Amling, CL ;
Bergstralh, EJ ;
Blute, ML ;
Slezak, JM ;
Zincke, H .
JOURNAL OF UROLOGY, 2001, 165 (04) :1146-1151
[2]   Do tumor volume, tumor volume ratio, type of nerve sparing and surgical experience affect prostate specific antigen recurrence after laparoscopic radical prostatectomy?: A matched pair analysis [J].
Ates, M. ;
Teber, D. ;
Goezen, A. S. ;
Tefekli, A. ;
Sugiono, M. ;
Hruza, M. ;
Rassweiler, J. .
JOURNAL OF UROLOGY, 2007, 177 (05) :1771-1775
[3]   Relapse after radical prostatectomy correlates with preoperative PSA velocity and tumor volume: Results from a screening population [J].
Berger, Andreas P. ;
Deibl, Martina ;
Strasak, Alexander ;
Bektic, Jasmin ;
Pelzer, Alexandre ;
Steiner, Hannes ;
Spranger, Robert ;
Fritsche, Gernot ;
Bartsch, Georg ;
Horninger, Wolfgang .
UROLOGY, 2006, 68 (05) :1067-1071
[4]   Prostate Total Tumor Extent Versus Index Tumor Extent-Which is Predictive of Biochemical Recurrence Following Radical Prostatectomy? [J].
Billis, Athanase ;
Meirelles, Luciana R. ;
Freitas, Leandro L. L. ;
Polidoro, Aline S. ;
Fernandes, Hamilton A. ;
Padilha, Mariana M. ;
Magna, Luis A. ;
Ferreira, Ubirajara .
JOURNAL OF UROLOGY, 2013, 189 (01) :99-104
[5]   Use of Gleason score, prostate specific antigen, seminal vesicle and margin status to predict biochemical failure after radical prostatectomy [J].
Blute, ML ;
Bergstralh, EJ ;
Iocca, A ;
Scherer, B ;
Zincke, H .
JOURNAL OF UROLOGY, 2001, 165 (01) :119-125
[6]   Long-Term Risk of Clinical Progression After Biochemical Recurrence Following Radical Prostatectomy: The Impact of Time from Surgery to Recurrence [J].
Boorjian, Stephen A. ;
Thompson, R. Houston ;
Tollefson, Matthew K. ;
Rangel, Laureano J. ;
Bergstralh, Eric J. ;
Blute, Michael L. ;
Karnes, R. Jeffrey .
EUROPEAN UROLOGY, 2011, 59 (06) :893-899
[7]   Early Detection of Prostate Cancer: AUA Guideline [J].
Carter, H. Ballentine ;
Albertsen, Peter C. ;
Barry, Michael J. ;
Etzioni, Ruth ;
Freedland, Stephen J. ;
Greene, Kirsten Lynn ;
Holmberg, Lars ;
Kantoff, Philip ;
Konety, Badrinath R. ;
Murad, Mohammad Hassan ;
Penson, David F. ;
Zietman, Anthony L. .
JOURNAL OF UROLOGY, 2013, 190 (02) :419-426
[8]   Tumour volume and high grade tumour volume are the best predictors of pathologic stage and biochemical recurrence after radical prostatectomy [J].
Chun, Felix K. -H. ;
Briganti, Alberto ;
Jeldres, Claudio ;
Gallina, Andrea ;
Erbersdobler, Andreas ;
Schlomm, Thorsten ;
Walz, Jochen ;
Eichelberg, Christian ;
Salomon, Georg ;
Haese, Alexander ;
Currlin, Eike ;
Ahyai, Sascha A. ;
Benard, Francois ;
Huland, Hartwig ;
Graefen, Markus ;
Karakiewicz, Pierre I. .
EUROPEAN JOURNAL OF CANCER, 2007, 43 (03) :536-543
[9]   Comparison of prostate cancer tumor volume and percent cancer in prediction of biochemical recurrence and cancer specific survival [J].
Chung, Benjamin I. ;
Tarin, Tatum V. ;
Ferrari, Michelle ;
Brooks, James D. .
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2011, 29 (03) :314-318
[10]   Maximal tumor diameter and the risk of PSA failure in men with specimen-confined prostate cancer [J].
Dvorak, T ;
Chen, MH ;
Renshaw, AA ;
Loffredo, M ;
Richie, JP ;
D'Amico, AV .
UROLOGY, 2005, 66 (05) :1024-1028